What This Bill Does
This Senate resolution designates June 6, 2026, as National Naloxone Awareness Day and encourages public education about naloxone, opioid overdose recognition, and overdose prevention. It does not create a new grant program or require a new spending amount; instead, it uses a national observance to promote awareness and access to naloxone. The resolution also calls on federal agencies including SAMHSA, CDC, ONDCP, and the DEA to keep supporting public awareness and prevention efforts. Its main effect is symbolic and educational, but it is aimed at people at risk of opioid overdose, their families, healthcare workers, first responders, and organizations that distribute naloxone.
- Designates June 6, 2026, as National Naloxone Awareness Day.
- Calls naloxone a safe and effective medication that can reverse opioid overdoses.
- Encourages federal, state, and local governments to support naloxone access and distribution.
- Calls on SAMHSA, CDC, ONDCP, DEA, and others to continue public awareness efforts.
- Highlights FDA action in 2024 on over-the-counter 10 mg naloxone and 4-year shelf life for 4 mg nasal spray.
Who This Bill Affects
For the general public, this resolution mostly affects people indirectly by promoting naloxone awareness rather than changing any benefits or obligations. If you are in a community touched by opioid overdoses, or if you work with the public as a healthcare professional, first responder, school staffer, or community organizer, the resolution reinforces efforts to learn overdose signs, keep naloxone available, and distribute it more widely. It does not itself provide money, coverage, or eligibility changes.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Public health advocates They see the resolution as a low-cost way to push education about overdose recognition and naloxone use. By normalizing naloxone and reducing stigma, they argue more bystanders will be prepared to save lives in emergencies.
- Families and communities affected by opioid use disorder They may support the measure because it directs attention to a medication that can prevent a fatal overdose. The resolution reinforces the message that naloxone should be available and that people should know how to use it.
- First responders and healthcare professionals They can view the observance as useful training reinforcement. The bill emphasizes safe administration and recognition of overdose signs, which aligns with emergency response and clinical practice.
- Fiscal conservatives skeptical of symbolic resolutions They may argue Congress should focus on treatment capacity, enforcement, or funding rather than creating another awareness day. From this perspective, the resolution is well-intentioned but does not directly change outcomes.
- Some overdose-response skeptics They may worry that awareness days can create a false sense of progress if they are not paired with sustained access to treatment, harm reduction, and follow-through. They could prefer concrete spending or regulatory changes over a commemorative measure.
Key Implications
-
““designates June 6, 2026, as National Naloxone Awareness Day””
This creates a formal national observance date, which agencies, schools, nonprofits, and local governments can use for outreach, training, and public messaging.
-
““naloxone is a safe and effective medication that can reverse opioid overdoses””
The resolution elevates naloxone as a core overdose-response tool, reinforcing the case for keeping it available in homes, workplaces, and emergency settings.
-
““encourages Federal, State, and local governments... to support increased naloxone access, education, and distribution efforts””
This is an encouragement rather than a mandate, so it does not force new spending or rules, but it signals where policymakers are being asked to focus attention.
-
““calls upon Federal agencies... to continue supporting public awareness of naloxone””
Named agencies such as SAMHSA, CDC, ONDCP, and DEA are specifically asked to keep pushing prevention messaging, which can influence federal communications and outreach priorities.
-
““over-the-counter sale of 10 milligram doses of naloxone””
The resolution references a recent FDA change that makes some naloxone easier to buy without a prescription, potentially lowering barriers for households and community organizations.
Latest Status
June 15, 2026
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2792; text: CR S2791-2792)
Will It Pass?
0% estimated chance of becoming law
This measure was introduced in the Senate on June 15, 2026, and was considered and agreed to without amendment by unanimous consent the same day. It is a Senate resolution with 17 cosponsors and bipartisan support from the sponsor list, and it had no committee or hearing action before passage in the Senate. As a commemorative resolution, it follows the common pattern of symbolic Senate measures that can move quickly when there is broad agreement.
Pass percentages are model estimates and may be inaccurate.
Related Bills
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.